[Comparative study of BCG vaccines: Polish, Danish and Japanese]

I Szczuka1, J Leowski, M Miller

  • 1Zakład Epidemiologii i Organizacji Walki z Gruźlica, Instytutu Gruźlicy i Chorób Płuc w Warszawie.

Insights

A comparative study of Polish, Danish, and Japanese BCG vaccines in 1111 Polish children found all vaccines induced strong tuberculin reactions. No significant differences were observed between the Polish vaccine and the other two.

Area of Science:

  • Immunology
  • Public Health
  • Pediatrics

Background:

  • Bacille Calmette-Guérin (BCG) vaccination is crucial for tuberculosis prevention.
  • Comparative efficacy studies of different BCG vaccine strains are essential for optimizing public health strategies.

Purpose of the Study:

  • To compare the immunogenicity of Polish, Danish, and Japanese BCG vaccine strains.
  • To evaluate post-vaccination tuberculin reactions in 12-year-old children.

Main Methods:

  • A comparative study involving 1111 school children aged 12 years in Poland.
  • Pre-vaccination tuberculin testing using 2 TU tuberculin RT-23 with Tween 80.
  • Assessment of post-vaccination tuberculin reactions 10 weeks after administration of Polish, Danish, or Japanese BCG vaccines.

Main Results:

  • All three BCG vaccines induced high levels of post-vaccination tuberculin reactions, with over 30% of children showing reactions exceeding 15 mm.
  • Mean post-vaccination reactions were 14.2 mm (Polish), 13.7 mm (Danish), and 14.9 mm (Japanese).
  • A statistically significant difference was found between Danish and Japanese vaccines, but not between the Polish vaccine and the other two. Larger post-vaccination indurations correlated with larger BCG scar diameters.

Conclusions:

  • The Polish, Danish, and Japanese BCG vaccines demonstrate comparable immunogenicity in inducing tuberculin sensitivity in 12-year-old children.
  • The findings support the effectiveness of the Polish BCG vaccine relative to the Danish and Japanese strains.
  • Further research may explore long-term protective efficacy and scar size correlation.

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Vaccine Production01:23

Vaccine Production

Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...